| Name | 1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)uracil |
|---|---|
| Synonyms |
1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-2,4(1H,3H)-pyrimidinedione
2’-Deoxy-2’-fluoro-b-D-abinouridine, antiviral anticancer agent 2'-Fluoro-2'-deoxy-abinofuranosyl-uridine 2'-Fluoro-2'-deoxy-β-Dabino-furanosyluridine 2’-Deoxy-2’-fluoro-beta-D-abinouridine 2'-Deoxy-2'-fluoro-beta-D-abinouridine 1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione 2,4(1H,3H)-PYRIMIDINEDIONE, 1-(2-DEOXY-2-FLUORO-BETA-D-ABINOFURANOSYL) 1-((2R,3S,4R,5R)-3-FLUORO-4-HYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-1H-PYRIMIDINE-2,4-DIONE 2'-Fluoro-2'-deoxy-β-D-abino-furanosyluridine 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-2-fluoro-β-D-abinofuranosyl) 2'-Fluoro-2'-deoxy-abino-Uridine 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione 2'-FLUORO 2'-DEOXYURACIL-BETA-D-ABINOFURANOSIDE 2'-Fluoro-abinofuranosyl-2'-deoxy-uridine 1-(2'-Deoxy-2'-fluoro-b-D-abinofuranosyl)uracil 1,3-Dimethyl-4-Amino-5-Formamide-Uracil FAU 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)pyrimidine-2,4(1H,3H)-dione 2’-fluoro-5-ethyl-1-beta-d-abinofuranosyluracil antiviral anticancer agent 2’-Deoxy-2’-fluoro-β-D-abinouridine 1-[(2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione 2'-Fluoro-2'-deoxyuridine 2'-Deoxy-2'-fluoro-D-abinouridine 1-(2-deoxy-2-fluoro-beta-d-abinofuranosyl)-uraci 2’-Deoxy-2’-fluoro-b-D-abinouridine 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione 2'-FLUORO-2'-DEOXYURACYL-BETA-D-ABINOFURANOSIDE 1-(2-Deoxy-2-fluoro-beta-D-abinofuranosyl)uracil 2-Deoxy-2'-fluoro-β-D-abinouridine a-2'-F-2'-dU 1-(2-Deoxy-2-fluoro-β-D-abinofuranosyl)uracil 2,4(1H,3H)-PyriMidinedione, 1-(2-deoxy-2-fluoro-b-D-abinofuranosyl) 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)uracil 2'-FANA-uridine |
| Description | 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Molecular Formula | C9H11FN2O5 |
| Molecular Weight | 246.19 |
| Exact Mass | 246.065201 |
| PSA | 104.55000 |
| LogP | -1.31 |
| Index of Refraction | 1.608 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
| HS Code | 2934999090 |
|---|
| Precursor 0 | |
|---|---|
| DownStream 2 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |